"アークトゥルス" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonARCT Stock Price, Quote & Chart | ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) - ChartMill
ARCT Stock Price, Quote & Chart | ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) ChartMill
A Spring Triangle of stars heralds the season - EarthSky
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipelin...
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress Yahoo Finance
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug - BioSpace
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug BioSpace
Exclusive: Arcturus raises $2.3M to make 3D immersive replays for live sports - Axios
Exclusive: Arcturus raises $2.3M to make 3D immersive replays for live sports Axios
Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conference Business Wire
Arcturus' stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial - Fier...
Arcturus' stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial Fierce Biotech
Arcturus Therapeutics Stock Plunges Over 58% Today: What’s Causing The Sell-Off? - Stocktwits
Arcturus Therapeutics Stock Plunges Over 58% Today: What’s Causing The Sell-Off? Stocktwits
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdin...
ARCTURUS Completes Their First New Record Since 2015 - Metal Injection
ARCTURUS Completes Their First New Record Since 2015 Metal Injection
This Biotech, Up 188% Since April, Just Crashed 50%. Here's Why. - Investor's Business Daily
This Biotech, Up 188% Since April, Just Crashed 50%. Here's Why. Investor's Business Daily
2025, November 9: Morning Moon Near Jupiter; Venus, Spica, and Arcturus in Twilight - When the Cu...
2025, November 9: Morning Moon Near Jupiter; Venus, Spica, and Arcturus in Twilight When the Curves Line Up
Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure - Seeking Alpha
Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure Seeking Alpha
Citi Lowers Price Target on Arcturus Therapeutics Holdings Inc. (ARCT) to $7, Maintains Neutral R...
Citi Lowers Price Target on Arcturus Therapeutics Holdings Inc. (ARCT) to $7, Maintains Neutral Rating Yahoo Finance
Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Good Position To Deliver On Growth Plans? - ...
Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Good Position To Deliver On Growth Plans? Yahoo Finance
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARC...
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets Yahoo Finance
Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presen...
Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presentation Nears Yahoo Finance
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Yahoo...
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress Yahoo Finance
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline - Yahoo Finance
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline Yahoo Finance
Arcturus Therapeutics Spotlights Inhaled mRNA CF Phase 2b Plan, FDA Talks for OTC Program at Summ...
Arcturus Therapeutics Spotlights Inhaled mRNA CF Phase 2b Plan, FDA Talks for OTC Program at Summit Yahoo Finance
Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last? - Yahoo Finance
Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last? Yahoo Finance
How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings - Yahoo Finance
How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings Yahoo Finance
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program - Yahoo Finance
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program Yahoo Finance
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance
Zacks.com featured highlights include Flux Power, Aura Minerals, Arcturus Therapeutics and Sterli...
Zacks.com featured highlights include Flux Power, Aura Minerals, Arcturus Therapeutics and Sterling Infrastructure Yahoo Finance
The Market Doesn't Like What It Sees From Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Rev...
Arcturus Therapeutics (ARCT) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Fi...
Arcturus Therapeutics (ARCT) is on the Move, Here's Why the Trend Could be Sustainable Yahoo Finance
Arcturus Therapeutics (ARCT): Evaluating Valuation After Cystic Fibrosis Trial Setback and Height...
Arcturus Therapeutics (ARCT): Evaluating Valuation After Cystic Fibrosis Trial Setback and Heightened Regulatory Scrutiny simplywall.st
Is Arcturus Therapeutics Stock Built to Withstand More Downside? - Trefis
Is Arcturus Therapeutics Stock Built to Withstand More Downside? Trefis
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - Yaho...
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress Yahoo Finance
Arcturus at Guggenheim Biotech Summit: Strategic Advances in mRNA Therapies - Investing.com
Arcturus at Guggenheim Biotech Summit: Strategic Advances in mRNA Therapies Investing.com
Arcturus Therapeutics: CF Setback Reinforces The Risks Of Its mRNA Therapeutics (ARCT) - Seeking ...
Arcturus Therapeutics: CF Setback Reinforces The Risks Of Its mRNA Therapeutics (ARCT) Seeking Alpha
Arcturus Closes US$2.3M Funding Round - Entrevestor
Arcturus Closes US$2.3M Funding Round Entrevestor
The ARCTURUS Computer Developed At Sydney University In The 1960s - Hackaday
The ARCTURUS Computer Developed At Sydney University In The 1960s Hackaday
Arcturus: A distinguished amphibian in the history of Coast Guard aviation - United States Coast ...
Arcturus: A distinguished amphibian in the history of Coast Guard aviation United States Coast Guard (.mil)
Arcturus stock cut to Neutral at Citi (ARCT:NASDAQ) - Seeking Alpha
Arcturus stock cut to Neutral at Citi (ARCT:NASDAQ) Seeking Alpha
Arcturus stops work on early-stage vaccine programs in effort to 'streamline resources' - Fierce ...
Arcturus stops work on early-stage vaccine programs in effort to 'streamline resources' Fierce Biotech
Why Is Arcturus Therapeutics Stock (ARCT) Down 55% Today? - TipRanks
Why Is Arcturus Therapeutics Stock (ARCT) Down 55% Today? TipRanks
CEO Has Led Arcturus Therapeutics Through 12 Eventful Years - San Diego Business Journal
CEO Has Led Arcturus Therapeutics Through 12 Eventful Years San Diego Business Journal
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies - BioSpace
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies BioSpace
Arcturus Therapeutics: High Hopes, High Hurdles For Its mRNA Pipeline (ARCT) - Seeking Alpha
Arcturus Therapeutics: High Hopes, High Hurdles For Its mRNA Pipeline (ARCT) Seeking Alpha
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Ne...
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next TipRanks
Arcturus Therapeutics Holdings Inc expected to post a loss of 82 cents a share - Earnings Preview...
Arcturus Therapeutics Holdings Inc expected to post a loss of 82 cents a share - Earnings Preview TradingView
Arcturus Therapeutics Announces CFO Departure and Replacement - TipRanks
Arcturus Therapeutics Announces CFO Departure and Replacement TipRanks
Arcturus Therapeutics Earnings Call: Progress Amid Challenges - TipRanks
Arcturus Therapeutics Earnings Call: Progress Amid Challenges TipRanks
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress - BioSpace
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress BioSpace
Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ....
Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ... Yahoo Finance
EMPEROR Feat. MORTIIS And FAUST, 1349, ARCTURUS Among First Acts Confirmed For Beyond The Gates 2...
EMPEROR Feat. MORTIIS And FAUST, 1349, ARCTURUS Among First Acts Confirmed For Beyond The Gates 2026 BraveWords
Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Tr...
Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade Yahoo Finance
The US shipyard Metal Shark delivered the new patrol vessel Arcturus to the Navy of the Dominican...
The US shipyard Metal Shark delivered the new patrol vessel Arcturus to the Navy of the Dominican Republic Zona Militar
Dennis Mammana: Follow the Arc to Arcturus with Spring Stargazing - Noozhawk
Dennis Mammana: Follow the Arc to Arcturus with Spring Stargazing Noozhawk
Charting New Waters: The Scientific Legacy of the Women of the Arcturus Expedition | Blog | Natur...
Charting New Waters: The Scientific Legacy of the Women of the Arcturus Expedition | Blog | Nature PBS
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candid...
Hercules is between 2 bright stars: Vega and Arcturus - EarthSky
Hercules is between 2 bright stars: Vega and Arcturus EarthSky
Ross Video and Arcturus launch a creative partnership for virtual production - Panorama Audiovisual
Ross Video and Arcturus launch a creative partnership for virtual production Panorama Audiovisual
Arcturus Therapeutics Holdings Inc. Securities Lawsuit Investigation - Claim Depot
Arcturus Therapeutics Holdings Inc. Securities Lawsuit Investigation Claim Depot
Arcturus Therapeutics shares plunge 56% after mixed phase 2 CF drug results - Invezz
Arcturus Therapeutics shares plunge 56% after mixed phase 2 CF drug results Invezz
Boötes the Herdsman and its bright star Arcturus - EarthSky
Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to...
UPDATED: CEFC, La Caisse ag-carbon platform buys CQ’s Arcturus Downs - Grain Central
UPDATED: CEFC, La Caisse ag-carbon platform buys CQ’s Arcturus Downs Grain Central
Brightest star in the sky? Find out which star is brightest tonight - BBC Sky at Night Magazine
Brightest star in the sky? Find out which star is brightest tonight BBC Sky at Night Magazine
Arcturus Therapeutics launches Phase I Avian Influenza trials in US - Clinical Trials Arena
Arcturus Therapeutics launches Phase I Avian Influenza trials in US Clinical Trials Arena
European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying ...
Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response - Inside Precision Medicine
Arcturus’ COVID-19 Vaccine Triggers Enhanced Immune Response Inside Precision Medicine
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, ...
‘Arcturus,’ a highly transmissible COVID variant eyed by the WHO, appears to have a new symptom. ...
‘Arcturus,’ a highly transmissible COVID variant eyed by the WHO, appears to have a new symptom. Here’s what you need to know University of Nebraska Medical Center
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” Gavi, the Vaccine Alliance
What to know about XBB.1.16, the 'Arcturus' variant - NBC News
What to know about XBB.1.16, the 'Arcturus' variant NBC News
The 'Arcturus' COVID Variant Is Already in the Bay Area. What We Know About XBB.1.16 - KQED
The 'Arcturus' COVID Variant Is Already in the Bay Area. What We Know About XBB.1.16 KQED
Arcturus – Aspera Hiems Symfonia - Decibel Magazine
Arcturus – Aspera Hiems Symfonia Decibel Magazine
New COVID variant Arcturus XBB.1.16 may cause unusual symptoms in kids, docs say - TODAY.com
New COVID variant Arcturus XBB.1.16 may cause unusual symptoms in kids, docs say TODAY.com
15-year-old boy fatally shot on Arcturus Lane - fox10tv.com
15-year-old boy fatally shot on Arcturus Lane fox10tv.com
Astranis’ Arcturus Satellite Malfunctions - Payload Space
Astranis’ Arcturus Satellite Malfunctions Payload Space
Arcturus' stock sinks after self-amplifying COVID-19 mRNA vaccine posts 55% efficacy in phase 3 -...
Arcturus' stock sinks after self-amplifying COVID-19 mRNA vaccine posts 55% efficacy in phase 3 Fierce Biotech
Arcturus: Facts About the 'Bear Guard' Star - Space
Arcturus in Boötes - BBC Sky at Night Magazine
Arcturus in Boötes BBC Sky at Night Magazine
Arcturus—a clinical-stage mRNA therapeutics and vaccines company - Nature
Arcturus—a clinical-stage mRNA therapeutics and vaccines company Nature
Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021 - CNBC
Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021 CNBC
Astranis officially announces UtilitySat to replace malfunctioning Arcturus satellite - Data Cent...
Astranis officially announces UtilitySat to replace malfunctioning Arcturus satellite Data Center Dynamics
What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye - University of Nebraska Medica...
What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye University of Nebraska Medical Center
Aerovironment buys Arcturus UAV in $405M deal - Defense News
Aerovironment buys Arcturus UAV in $405M deal Defense News
CSL Seqirus and Arcturus Ink $4.3 Billion mRNA Vaccine Deal - BioSpace
CSL Seqirus and Arcturus Ink $4.3 Billion mRNA Vaccine Deal BioSpace
Arcturus Raises $11 Million - Los Angeles Business Journal
Arcturus Raises $11 Million Los Angeles Business Journal
Arcturus: The Mysteries of the Red Giant Star - The Old Farmer’s Almanac
Arcturus: The Mysteries of the Red Giant Star The Old Farmer’s Almanac
What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye - Forbes
What To Know About ‘Arcturus’: New Covid Variant Causing Pink Eye Forbes
Arcturus introduces the world’s first high-performance volumetric video codec - Computer Graphics...
Arcturus introduces the world’s first high-performance volumetric video codec Computer Graphics World
What to Know About the New COVID-19 Strain 'Arcturus' - Healthline
What to Know About the New COVID-19 Strain 'Arcturus' Healthline
Arcturus homecoming - MIT Energy Initiative
Arcturus homecoming MIT Energy Initiative
What to know about Arcturus, a new coronavirus subvariant the WHO is tracking - The Washington Post
What to know about Arcturus, a new coronavirus subvariant the WHO is tracking The Washington Post
Meet Arcturus: Guardian of the Bear - Sky & Telescope
Meet Arcturus: Guardian of the Bear Sky & Telescope
EC approves CSL and Arcturus’ Kostaive - The Pharma Letter
EC approves CSL and Arcturus’ Kostaive The Pharma Letter
Microsoft’s MRCS rehomed at Arcturus - Jon Peddie Research
Microsoft’s MRCS rehomed at Arcturus Jon Peddie Research
May 2018 Feature – Arc to Arcturus and Speed on to Spica - UA Little Rock
May 2018 Feature – Arc to Arcturus and Speed on to Spica UA Little Rock
Orange Arcturus sparkles after sunset - EarthSky
Volumetric team Arcturus expands with help from Epic and Autodeck - fxguide
Volumetric team Arcturus expands with help from Epic and Autodeck fxguide
EYES TO THE SKY: Celestial spring—Arcturus, Leo the Lion all night - The Berkshire Edge
EYES TO THE SKY: Celestial spring—Arcturus, Leo the Lion all night The Berkshire Edge
Arcturus JV scored $115M in Japanese grants to boost mRNA manufacturing - Fierce Pharma
Arcturus JV scored $115M in Japanese grants to boost mRNA manufacturing Fierce Pharma
‘Arcturus,’ a highly transmissible COVID variant eyed by the WHO, appears to have a new symptom. ...
Arcturus Therapeutics ousts CEO Joseph Payne - Fierce Biotech
Arcturus Therapeutics ousts CEO Joseph Payne Fierce Biotech
New Co-Op Commander: Arcturus Mengsk — StarCraft II - Blizzard News
New Co-Op Commander: Arcturus Mengsk — StarCraft II Blizzard News